Qualitative analyses of focal hepatic preneoplasia are relatively easy and fast but hypothesis tests based on these analyses often lack statistical power. Evaluating focal hepatic preneoplasia quantitatively, on the other hand, requires more effort but is rewarded by an increased ability to detect differences between treatment groups and by the possibility to investigate the mechanism of a treatment under study. Due to the stereological problems inherent in the data a statistical analysis that concentrates on the evaluation of area fraction will provide clear results whereas the analysis of focal transection density and size distribution can produce misleading results. In addition, the area fraction is a valid variable even in the presence of confluent foci. The number and size distribution of focal transections in liver sections cannot be directly translated to the number and sizes of foci in the liver. As no general statements about the relationship between focal transection density and foci density as well as between focal transection size and foci size distribution can be made, there is need for a parametric mechanistic model to link the number and size distribution of focal transections to those of the underlying foci. The stereological problem therefore can be avoided by introducing a model for foci appearance and change of volume that then can be used to conclude whether the treatment induces foci and whether it changes their volume.
INTRODUCTION
The occurrence of focal hepatic preneoplasia has proven to be a valuable indicator of the ability of a treatment to cause liver cancer. Although the number of liver cancers induced in rats by chemicals is generally believed to be orders of magnitude lower than that of liver foci in the usual timeframe of these experiments, there is a clear correlation between the 2 endpoints. Focal hepatic preneoplasia, therefore, represents a sensitive marker of carcinogenic response.
The main aim in quantitative studies on preneoplastic liver lesions is the analysis of the carcinogenic potential of the oncogenic agent studied. In addition, the finding that a compound alters the number of focal transections or the size distribution of the transections may give indications about the mechanism of action of the compound. However, the measurements are made in 2-dimensional liver sections and inference about the reality in 3-dimensional liver is limited by the stereological problem. This problem is described briefly by the fact that the probability of a focus to be cut increases with its size. Therefore, large foci will be overrepresented in liver sections compared to small ones, and the number of transections observed in a liver section depends on both the number of foci in the liver and their size distribution. Morris (7) has clearly described the difficulties caused by the stereological problem that arise when focal transection data are statistically analyzed.
Qualitative Evaluation of Hepatic Preneoplasia
Liver sections are routinely examined qualitatively when potentially carcinogenic compounds are tested. The most simple evaluation classifies sections as positive if they con- tain at least 1 focus transection, which however represents a substantial reduction of the information that is contained in the sections. Table 1 shows data from a rat hepatocarcinogenesis stop experiment with oral exposure to 12 mg/kg body wt N -nitrosomorpholine for 7 weeks; 10 (in one group 8) control animals and 5 (in one group 4) treated animals were sacrificed at 8 time points, and H&E stained liver sections were evaluated morphometrically (11) . For the present analysis, all types of foci were combined. The table shows that all of the treated animals have foci from the first sacrifice time point onward. Foci incidence in control animals rises fast and reaches 100% after one year. It is apparent that a difference in foci incidence between treated and control animals is not significant in Fisher's exact test with exception of the first sacrifice time point.
More detailed qualitative evaluations of hepatic preneoplasia data are performed in industrial research laboratories. Instead of exclusively evaluating the presence or absence of foci in the section, the area fraction is classified into a three-or four-grade scale by visual inspection of the section, a procedure that leads to an increase in the power of studies compared to the qualitative evaluation presented above.
Quantitative Evaluation of Hepatic Preneoplasia
The quantitative analysis of foci data involves rather timeconsuming evaluation of the liver sections using a morphometric device. GST-p stained sections can be analyzed using a half-automatic device that can be programmed to recognize the foci by detection of user-defined contrasts in the digitized image. However, manual correction is necessary to exclude cholangiocytes that are also stained by the marker.
The result of a morphometric analysis is one data set per liver section that contains the total area of the liver section and each individual area of focal transections that were identified. In the evaluation of H&E stained sections, the phenotype of each focus is recorded in addition. As a rule, foci under a 121 0192-6233/03$3.00+$0.00 122 KOPP-SCHNEIDER TOXICOLOGIC PATHOLOGY fixed minimum size are not recorded or discarded from the study.
From the raw data three variables are extracted for the statistical analysis. Adding all focal transection areas and dividing the result by the total liver section area yields the area fraction occupied by foci. The area fraction is an unbiased estimate of the volume fraction whenever the foci are randomly distributed in the liver. The profile density is calculated by dividing the number of focal transections by the liver section area. The third variable for evaluation is the size of the transections that can be visualized by histograms or by empirical cumulative distribution function. Table 1 shows in addition to the qualitative analysis of foci data the evaluation of the area fraction. It is apparent that results are significant for the evaluation of area fraction when they are not significant for incidence. Although virtually all control animals have foci at later time points, they do not have many of them or the size of the foci is small. In contrast, the foci burden of treated animals is much higher. This is reflected in the area fraction of foci, showing an increase of about two orders of magnitude in treated animals in comparison to control. When comparing the area fraction of foci between control and treated animals we see mostly highly significant results in the two-sided Wilcoxon rank-sum test. If there is any possibility, liver sections should be analyzed quantitatively to allow for an increased power of a study. As shown in Table 1 , a quantitative analysis of the area fraction of foci may yield highly significant differences between experimental groups where foci incidence does not allow to discriminate between them.
The quantitative evaluation of foci data can be used to investigate several questions. The question that is most directly answered is whether a treatment changes the volume fraction of foci because the area fraction can be calculated straightforwardly from the quantitative data and represents an unbiased estimate of the volume fraction. In addition, the evaluation of the area fraction is not affected by confluent foci, which may represent a serious problem at high doses of toxic chemicals. However, researchers are often interested in alterations in number of foci and their size induced by the treatment and in the mechanism of the treatment effect. As Morris (7) points out, testing statistical hypotheses about the area fraction does not provide information about the number and sizes of foci because large area fractions may be due to small numbers of large foci, or to large numbers of small foci or to large numbers of large foci.
Stereology
Inference about the number of foci and their size distribution is limited by the fact that foci can only be observed in liver sections and, therefore, stereological considerations have to be taken into account. The main difficulty when analyzing data obtained from sections through a volume is that the probability to observe a focal transection increases with the size of the corresponding focus. Hence larger foci are overrepresented in liver sections whereas small foci are underrepresented. When cutting a sphere, the observed transection circle has a diameter depending on the distance of the section plane from the sphere center. The major assumption that has to be made for the following stereological considerations is that foci are randomly distributed in the liver. In addition, all examples presented are based on the assumption that the objects are spheres. However, preneoplastic liver foci are not always spherical and especially large foci have nonspherical shapes (4) . The stereology of nonspherical foci will, in any case, involve the problems arising for spheres. Liver sections are about 2-µm thick. Compared to the diameter of single cells of about 24 µm, the thickness of the sections can be ignored and stereological methods for thin sections can be applied.
Next, two situations are discussed in which inference drawn from 2-dimensional data may contradict the 3-dimensional reality. Although the situations may seem rather artificial, they illustrate the difficulty to extrapolate from the size distribution of the transections to the size distribution of the foci. Both examples concern the comparison of two subpopulations of foci with different size distributions, assuming a spherical shape of the foci.
The first situation concerns two populations, one of which consists of spheres with diameter 3. The second population consists of an equal mix of two subpopulations, small spheres with diameter 1 and large spheres with diameter 4. The mean diameter of the first population is 3, whereas the mean diameter of the second population is 2.5, the second population therefore being smaller in mean than the first. Considering the 2-dimensional transections, their mean diameter is 2.4 for the first distribution, and 2.7 for the second distribution (8) . Hence, an inversion in the order of the mean diameters is observed. It is also noticeable that in the second distribution, the mean diameter of the 2D-transections exceeds the mean diameter of the spheres.
The second situation concerns the ordering of cumulative size distribution functions for spheres. two populations. The graph shows that the dashed cumulative distribution function (corresponding to population 1) lies above the cumulative distribution function denoted by the solid line (corresponding to population 2). This order means that the probability of a transection being smaller than a fixed size is always larger in population 1 than in population 2.
Thus, population 1 has smaller transections than population 2. Figure 1b shows the cumulative distribution function for the spheres of both populations from which the transections were made. Obviously, the cumulative distribution functions intersect and, hence, the order of cumulative distribution functions observed in 2D is disturbed in 3D. Therefore, although the 
Reconstruction of the 3D-Size Distribution from the 2D-Transection Size Distribution
Several methods have been proposed to reconstruct the 3-dimensional situation from the observation of transections (2, 1, 7, 9, 10). All of these methods are based on Wicksell's formulas (12) that relate the distribution of the sphere diameters to the distribution of spherical transection diameters and vice versa. For the validity of Wicksell's formulas the crucial assumption is the spherical shape of foci and their random distribution in the liver. A number of methods concentrate on the estimation of the number of spheres in the volume, ie, the sphere density, from the observed number of transections and their diameters. Some approaches estimate a histogram for the sphere diameters from a histogram for the profiles using discretized versions of the Wicksell formula. Unfortunately, all approaches are unstable in the presence of a limited number of observed transections, which means that small changes in the data can result in large changes in the sphere size distribution and the sphere density. This is especially true for the finding of very small profiles. Another unpleasant property of some of the estimates is their infinite variance.
The number of focal transections observed in carcinogenicity studies, especially in short-term carcinogencitiy studies, is often too low to use the reconstruction methods for reliable estimates of focal density and size distribution. However, comparisons based on reconstructed data often show the same levels of significance than comparisons based on the original transection data. Therefore, the reconstruction does not provide any further information for statistical purposes but is at present too unreliable to be used for numerical comparisons and mechanistic inference.
Model-Based Approach for Evaluation of Hepatic Preneoplasia
The main difficulties in the statistical analysis of focal hepatic preneoplasia result from stereology, ie, in the fact that the 3-dimensional reality cannot be observed but has to be inferred from observations from a plane cutting the volume. The previous section has shown that the attempts to reconstruct the 3-dimensional situation will not solve these problems due to the disadvantageous characteristics of the estimators.
As mentioned earlier, if a compound alters the size distribution of spherical foci in comparison to another compound by increasing their size by a fixed factor, then the relationship between transection diameter size distributions can be translated to the sphere diameter size distribution. This assumption probably is too simplistic a model of carcinogenic effect but it illustrates how model assumptions can relieve stereological problems.
Difficulties in the statistical analysis of hepatic preneoplasia can be eliminated by basing the analysis on a mechanistic model which describes the appearance and the change in volume of foci. Several models have been developed to describe foci data. All of these models assume that foci appear randomly in space and time and use the concept of a Poisson process. The models are different by the way in which the change in volume and in phenotype of foci is described.
There are basically two models available for the description of foci data. The multistage model with clonal expansion of intermediate cells describes the process of foci appearance and foci volume change at the cellular level, assuming that the formation of altered hepatocytes or the change in phenotype of hepatocytes is caused by a mutational event. Depending upon the number of sequential foci types that are to be modeled, the model needs to be extended to incorporate eg, three sequential types (3), or it has to be reduced to a onestage model if only one type of focus-eg, enzyme-altered foci-is observed (eg, 6). A four-stage model with clonal expansion of intermediate cells is depicted in Figure 2 . In this model, a normal cell becomes malignant by sequentially The second model for the description of foci data is the color-shift model in which it is assumed that all cells in a colony of altered hepatocytes change their phenotype more or less simultaneously rather than by mutation of single cells of the colony. This approach formalizes the hypothesis that changes in the phenotype of foci are due to a field effect to which all cells in a focus are exposed. As in the multistage model, foci appear according to a Poisson process. Foci are assumed to have a spherical shape. Initially, they may consist of single cells or they may already contain a whole cluster of cells. Foci increase their volume by clonal expansion and/or recruitment of neighbouring cells. When focal lesions are generated they all have the same phenotype. The phenotype changes sequentially over time, ie, each focal lesion may pass through a sequence of phenotypes, and changes in phenotype are irreversible. The model is depicted in Figure 3 .
Both the multistage and the color-shift model describe the appearance and the change in volume of foci in the 3-dimensional organ. Wicksell's formulas are used to transform the 3-dimensional size distribution of the foci to the distribution of focal transections. The resulting expressions are then used to apply the models to the observed focal transection data by maximum likelihood methods.
Both models include parameters that can be interpreted in a biological framework. Therefore, estimates of model parameters obtained from the application of the models to data can be compared with measurements of biological parameters such as cell cycle time. In particular dose can explicitely be incorporated into the parameters. Using likelihood ratio tests the models can be used to examine hypotheses about the effect of the compound on the model parameters. Specifically, one can test whether the compound has an effect on the rate of appearance of foci, whether it has an effect on the volume change of foci or if the effect of the compound is a combination of both. In addition, the models allow for a quantification of the effect and hence can be used to compare the potency of different compounds.
All model-based analyses can only be performed on the basis of a quantitative analysis of focal hepatic preneoplasia. Any conclusions, however, are dependent on the model describing reality appropriately. The routine analysis of foci data by mechanistic models of foci formation and growth is unfortunately hindered by difficult computational procedures which are necessary for the implementation of models.
